WHC is still in active development. Read this to understand our approach.
depiction of PSPGQHXMUKWNDI-UHFFFAOYSA-N.svg
tripsit

coluracetam

Verificar en tripsit

psychonaut

Coluracetam

Verificar en psychonaut

isomerdesign

Coluracetam

Verificar en isomerdesign

druglab

Coluracétam

Verificar en druglab

drugmap

Coluracetam

Verificar en drugmap

wiki

Coluracetam

Verificar en wiki

Data

InChI: InChI=1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23)

Sinónimos: FT-0697594,bci-540,ZINC4939,MKC-231,1-Pyrrolidineacetamide, 2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro(2,3-b)quinolin-4-yl)-,CCG-267931,DTXSID60159386,N-{2,3-DIMETHYL-5H,6H,7H,8H-FURO[2,3-B]QUINOLIN-4-YL}-2-(2-OXOPYRROLIDIN-1-YL)ACETAMIDE, Neurons growth promoting compound (major depressive disorder/anxiety), BrainCells,A857829,463C819,V6FL6O5GR7,N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrroli din-1-yl)acetamide,N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide,HMS3886I15,135463-81-9,2-(2-Oxypyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)acetoamide,MFCD00901416,DS-14004,N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxo-1-pyrrolidinyl)acetamide,EX-A739,Coluracetam,C3689,Q3683872,NCGC00378715-01,N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide,UNII-V6FL6O5GR7, MKC-231,BCP07168,J-690145, High-affinity choline uptake facilitator (CNS disorders), Mitsubishi,AC-31948,AMY32492,HY-17553,Coluracetam;MKC-231;BCI-540,BCI-540,s5222,CHEMBL37935,Coluracetam [INN],SCHEMBL194780, High-affinity choline uptake facilitator (depression/ anxiety), BrainCells,AKOS015842255,MKC 231

Estimated data

Solubilidad: -4.281 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 27.1% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.